NDC 70461-019
FLUAD
Influenza Vaccine, Adjuvanted
FLUAD is a Intramuscular Injection, Suspension in the Vaccine category. It is labeled and distributed by Seqirus, Inc.. The primary component is Influenza A Virus A/brisbane/02/2018 Ivr-190 (h1n1) Antigen (formaldehyde Inactivated); Influenza A Virus A/kansas/14/2017 X-327 (h3n2) Antigen (formaldehyde Inactivated); Influenza B Virus B/maryland/15/2016 Antigen (formaldehyde Inactivated).
| Product ID | 70461-019_97c3669d-ac04-4c97-b2ab-2ce4d0bf6e12 |
| NDC | 70461-019 |
| Product Type | Vaccine |
| Proprietary Name | FLUAD |
| Generic Name | Influenza Vaccine, Adjuvanted |
| Dosage Form | Injection, Suspension |
| Route of Administration | INTRAMUSCULAR |
| Marketing Start Date | 2015-11-24 |
| Marketing End Date | 2020-07-31 |
| Marketing Category | BLA / BLA |
| Application Number | BLA125510 |
| Labeler Name | Seqirus, Inc. |
| Substance Name | INFLUENZA A VIRUS A/BRISBANE/02/2018 IVR-190 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/KANSAS/14/2017 X-327 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/MARYLAND/15/2016 ANTIGEN (FORMALDEHYDE INACTIVATED) |
| Active Ingredient Strength | 15 ug/.5mL; ug/.5mL; ug/.5mL |
| NDC Exclude Flag | N |
Packaging
NDC 70461-019-03
10 SYRINGE, GLASS in 1 CARTON (70461-019-03) > .5 mL in 1 SYRINGE, GLASS (70461-019-04)
| Marketing Start Date | 2015-11-24 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 70461-019-03 [70461001903]
FLUAD INJECTION, SUSPENSION
| Marketing Category | BLA |
| Application Number | BLA125510 |
| Product Type | VACCINE |
| Billing Unit | ML |
| Marketing Start Date | 2015-11-24 |
| Marketing End Date | 2020-07-31 |
NDC 70461-019-04 [70461001904]
FLUAD INJECTION, SUSPENSION
| Marketing Category | BLA |
| Application Number | BLA125510 |
| Product Type | VACCINE |
| Billing Unit | ML |
| Marketing Start Date | 2015-11-24 |
| Marketing End Date | 2020-07-31 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| INFLUENZA A VIRUS A/BRISBANE/02/2018 IVR-190 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED) | 15 ug/.5mL |
NDC Crossover Matching brand name "FLUAD" or generic name "Influenza Vaccine, Adjuvanted"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 70461-018 | FLUAD | Influenza Vaccine, Adjuvanted |
| 70461-019 | FLUAD | Influenza Vaccine, Adjuvanted |
| 70461-020 | FLUAD | influenza vaccine, adjuvanted |
| 70461-120 | FLUAD QUADRIVALENT | influenza vaccine, adjuvanted |
| 70461-121 | FLUAD QUADRIVALENT | influenza vaccine, adjuvanted |
Trademark Results [FLUAD]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 FLUAD 86857445 5461626 Live/Registered |
Seqirus UK Limited 2015-12-22 |
 FLUAD 86443221 5069225 Live/Registered |
SEQIRUS UK LIMITED 2014-11-03 |
 FLUAD 77767895 3953086 Dead/Cancelled |
SEQIRUS S.R.L. 2009-06-25 |
 FLUAD 77459412 3543434 Dead/Cancelled |
Novartis Vaccines and Diagnostics S.r.l. 2008-04-28 |
 FLUAD 76055946 2555046 Dead/Cancelled |
NOVARTIS VACCINES AND DIAGNOSTICS S.R.L. 2000-05-25 |
 FLUAD 75109153 not registered Dead/Abandoned |
Chiron Corporation 1996-05-24 |
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.